Company Filing History:
1 out of 832,761 Years Active: 2023
Title: The Innovative Contributions of Guillaume Petitjean
Introduction
Guillaume Petitjean is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the area of drug safety. His work focuses on preventing risks associated with drug-induced QT interval prolongation, a critical concern in pharmacology.
Latest Patents
Guillaume Petitjean holds a patent titled "Prevention of the risks associated with drug-induced QT interval prolongation by using a specific inhibitor of the production of ROS of mitochondrial origin." This patent outlines a method for treating subjects to reduce the risk of QT space prolongation associated with the intake of drugs known to prolong QT space. The method includes administering at least one specific inhibitor of mitochondrial ROS production, such as anethole trithione (ATT), 4-OH-anethole trithione (ATX), or an ATX ester, alongside the drug known to prolong QT space.
Career Highlights
Throughout his career, Guillaume Petitjean has demonstrated a commitment to advancing medical safety through innovative solutions. His research and patent reflect a deep understanding of the complexities involved in drug interactions and their potential risks.
Collaborations
Guillaume has collaborated with notable individuals in his field, including Olivier Petitjean and Elodie Petitjean. These collaborations have likely contributed to the development and refinement of his innovative ideas.
Conclusion
Guillaume Petitjean's work exemplifies the importance of innovation in medicine, particularly in enhancing drug safety. His patent serves as a valuable resource for addressing the risks associated with drug-induced QT interval prolongation.